ClinicalTrials.gg
RecruitingNCT04446585CARAMBAUpdated Sep 15, 2023

Cardiac Arrest in Residential Areas With Mobile First-responder Activation

An interventional study of Automated External Defibrillator (AED) and Training in cardiopulmonary resuscitation and AED use in Out-Of-Hospital Cardiac Arrest, sponsored by Emergency Medical Services, Capital Region, Denmark. Recruiting at 1 site in Denmark. Open to participants aged 8 Years and older. Per ClinicalTrials.gov, last updated 2023-09-15.

Sponsored by Emergency Medical Services, Capital Region, Denmark · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Dec 2021; still recruiting 4 years 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
260
Allocation
Randomized
Ages
8 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 12 studies in Out-of-Hospital Cardiac Arrest by Emergency Medical Services, Capital Region, Denmark — 1 open to participants now, 1 under way, none of them phase 3. Out-of-Hospital Cardiac Arrest · Emergency Medical Services, Capital Region, Denmark.

Started
2021
the only one that year
No phase
4 of 12
1 open now
Registered
10th of 12
by date

Among the 12 studies in Out-of-Hospital Cardiac Arrest by Emergency Medical Services, Capital Region, Denmark, this one is the only one that started in 2021, is one of 4 with no phase, and was the 10th registered.

Out-of-Hospital Cardiac Arrest

314 studies on the registry are indexed under Out-of-Hospital Cardiac Arrest; 93 are open to participants now.

Browse Out-of-Hospital Cardiac Arrest studies →

Open to participants now

1 of the 12 studies in Out-of-Hospital Cardiac Arrest by Emergency Medical Services, Capital Region, Denmark is open now, in 1 country.

By country, each count listing its studies:

Where they have run

Who these studies take

Of the 66 Out-of-Hospital Cardiac Arrest studies recruiting now, 46 (70%) set no upper age limit and 13 (20%) stop at 75 or younger; 8 take children under 18; 7 take healthy volunteers.

This study: 8 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 12 studies in Out-of-Hospital Cardiac Arrest by Emergency Medical Services, Capital Region, Denmark, or all of them as a file.
02

Study summary

The study aims to increase proportions of bystander defibrillation during out-of-hospital cardiac arrest (hereof referred to as cardiac arrest) in residential areas with a high density of cardiac arrests. The intervention consists of Automated External Defibrillators (AEDs) and residents' involvement in resuscitation through training and enrollment as citizen responders.

Read the detailed description

Survival decreases by 10% for every minute that passes after a cardiac arrest until defibrillation. Despite an increasing number of available AEDs, survival and defibrillation rates in residential areas remain poor. Efforts to increase bystander defibrillation has the potential to improve survival. Through the strategic deployment of AEDs, training, and recruitment of residents as citizen responders, we aim to improve proportions of bystander defibrillation and 30-day survival in densely populated residential areas with a high density of cardiac arrests.

03

Conditions studied

  • Out-Of-Hospital Cardiac Arrest

Keywords

  • Suddan cardiac arrest
  • Heart Arrest
  • Heart Diseases
  • Cardiovascular Diseases
04

Who can participate

Ages eligible
8 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All witnessed cardiac arrests recognized registered in the Danish Cardiac Arrest Registry occurring within the study sites. This excludes non witnessed cardiac arrests.
  • Witnessed cardiac arrest
  • Non-traumatic etiology, this excludes intoxication, drowning or suicide.

Exclusion criteria

Exclusion Criteria:

  • Cardiac arrest occurring in a nursing home
  • Cardiac arrest not treated by the EMS due to ethical reasons or obvious signs of death
  • Not true cardiac arrest (suspected, but not verified)
  • Cardiac arrests witnessed by the emergency medical personnel
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
260 participants (estimated)

Study arms

  • No intervention
    Control sites

    * For all 1-1-2 calls with suspected cardiac arrest to the emergency dispatch center will activate a two-tiered response consisting of dispatch of an ambulance with an emergency medical technician, a physician-staffed mobile emergency care unit, and citizen first responders through the Heart Runner app. * The medical dispatcher offers telephone assisted cardiopulmonary resuscitation (CPR) to bystanders. Furthermore, if more than two bystanders are present and an AED is accessible within 1½ minute travel distance (depending on the type of terrain), then one bystander is guided to localize and retrieve the AED.

  • Experimental
    Intervention sites

    As a supplement to the standard care as described in the control arm, the following will be supplied: * Strategical deployment of AEDs with 24:7 availability and 1½ minute walking distance to every residence within the area. The AEDs will be registered with the AED network and thus linked to the emergency dispatch center. * The emergency dispatch center will retrieve data from used AEDs. * For each interventional area, approximately 120 residents will receive a course in CPR and AED use and subsequently be recruited as citizen responders so that they can be activated through the HeartRunner app in case of a nearby cardiac arrest.

    Device: Automated External Defibrillator (AED) · Other: Training in cardiopulmonary resuscitation and AED use · Other: Activation of citizen responders

Interventions

  • DeviceAutomated External Defibrillator (AED)

    Deployment of AEDs

  • OtherTraining in cardiopulmonary resuscitation and AED use

    Residents will undergo 30-minute courses at study start and if needed during the trial period. During the course they will also be recruited as citizen responders

  • OtherActivation of citizen responders

    Citizen responders will be activated in case of suspected cardiac arrest through the heart runner app.

06

What researchers measure

Primary outcomes

  1. Bystander defibrillation

    Proportion of bystander defibrillation of witnessed cardiac arrests

    Time frame: Up to five years after implementation of the intervention

Secondary outcomes

  1. 30-day survival

    Proportion of patients alive 30 days after date of cardiac arrest

    Time frame: 30 days after date of cardiac arrest

07

Study locations

1 of 1 sites recruiting
  • Emergency Medical Services Copenhagen
    Ballerup, The Capital Region 2750, Denmark
    Recruiting
    • Anne J Jørgensen, MD · Contactanne.juul.joergensen.02@regionh.dk · +45 60 62 91 14
    • Fredrik Folke, MD, PhD · Principal investigator
    • Carolina M Hansen, MD, PhD · Principal investigator
    • Anne J Jørgensen, MD · Sub investigator
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2021 (actual). Primary completion is estimated for Jan 2027, 61 months after the start.

Of 93 non-industry interventional studies with no phase under Out-of-Hospital Cardiac Arrest, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 57. This study's planned 61 months is above that.

Counting every sponsor, half of 95 studies reached it within 34 months; a quarter within 19 and three quarters within 57.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 16, 2020
First posted
Jun 25, 2020
StartActual
Dec 1, 2021
Primary completionEst.
Jan 2027
CompletionEst.
Jan 2027
Last update
Sep 15, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 15, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04446585
Lead sponsor
Emergency Medical Services, Capital Region, Denmark
Collaborators
TrygFonden, Denmark, Zoll Medical Corporation, Danish Heart Foundation
Responsible party
Fredrik Folke (M.D., PhD, Professor, Emergency Medical Services, Capital Region, Denmark) — Principal investigator
First posted
Jun 25, 2020
Start date
Dec 1, 2021
Primary completion
Jan 2027 (estimated)
Completion
Jan 2027 (estimated)
Last update
Sep 15, 2023

Study contacts

Anne J Jørgensen, MD
Contact
anne.juul.joergensen.02@regionh.dk
+45 60 62 91 14
Fredrik Folke, MD, PhD
Contact
ff@heart.dk
+45 28 18 29 78
Fredrik Folke, MD, PhD
principal investigator · EMS Copenhagen
Carolina M Hansen, MD, PhD
principal investigator · EMS Copenhagen

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion